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Assessment of the Use of Non-Pharmacological Methods for Managing
Depression in Patients with Myotonic Dystrophy (DM) and Facioscapulohumeral
Muscular Dystrophy (FSHD)
Abstract
Background: Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are two
types of muscular dystrophies with multi-system manifestations.
Purpose: The purpose of this study was to determine 1: the prevalence of depression in patients with
myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) and 2: which nonpharmacological methods DM and FSHD patients are using to manage their depression.
Methods: A survey was conducted using the online system, Qualtrics. The voluntary and anonymous
survey was emailed to 1,205 eligible patients from the National Registry for DM and FSHD Patients and
Family Members at the University of Rochester. Participants were at least 18 years old, a member of the
registry, and diagnosed with DM or FSHD. The 65 question survey included questions on basic
demographic information, depression diagnosis, medication use and effectiveness, and nonpharmacological management. Surveys were collected between May 2017 and August 2017 and the
responses were analyzed and compared to the general population. The study was approved by the St.
John Fisher College Institutional Review Board and the Registry Scientific Advisory Committee.
Results: Of the 1,205 surveys that were sent, 466 patients responded. A total of 46 percent of patients had
DM (DM1 30 percent, n=138/460 and DM2 16 percent, n=75/460) and 48 percent (n=223/460) of
respondents had FSHD. Of the study respondents, 34 percent (n=150/436) reported being diagnosed with
depression, while 8 percent (n=24/294) feel depressed, but haven’t been diagnosed. Non-pharmacological
techniques used by patients who were diagnosed with depression or feel that they are depressed
included: exercise (33 percent, n=57/150), relaxation techniques once per week (51 percent, n=50/98),
and visiting a counselor or therapist once per week (11 percent, n=4/37). The most common type of
relaxation technique used was meditation (52 percent, n=77/147) followed by yoga (18 percent, n=24/
147). In conclusion, 32 percent (n=34/107) stated that relaxation techniques helped them, and 49 percent
(n=52/107) stated that relaxation techniques may have helped them.
Conclusion: Patients with both DM and FSHD have been diagnosed with depression. To manage their
depression, and similar to what occurs in the general population, DM and FSHD patients are using a
combination of both pharmacologic and non-pharmacologic strategies. DM and FSHD patients also
believe that these non-pharmacologic methods, which include exercise, counseling, and relaxation
techniques are helpful in their managing depression.
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of the use of non-pharmacological methods for managing depression in patients with myotonic
dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD)
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St. John Fisher College, Wegmans School of Pharmacy, Rochester, NY
Background
Myotonic dystrophy (DM) and faciscapulohumeral muscular
dystrophy (FSHD) are two forms of muscular dystrophy found
in adults. They are characterized by weakness in the face, neck,
hands, and shoulders, as well as multi-system complications1.
Many of these patients have been diagnosed with depression,
and to manage this they are using both pharmacological and
non-pharmacological techniques.

Purpose
The purpose of this study was to identify the prevalence of
depression in this patient population and the medications and
non-pharmacological techniques that patients use to manage
depression.

Table 2. Age and disease state
Age (years)
18-24
25-34
35-44
45-54
55-64
65-74
75 and older

DM1 (n=132)

DM2 (n=70)

12 (9%)
35 (27%)
30 (23%)
36 (27%)
15 (11%)
4 (3%)

1 (1%)
12 (17%)
17 (24%)
19 (27%)
19 (27%)
2 (3%)

Figure 2. Exercise techniques used
FSHD (n=203)
2 (1%)
15 (7%)
22 (11%)
34 (17%)
65 (32%)
51 (25%)
14 (7%)
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Strength Training
Walking
Yoga

18%

27%
8%

Figure 1. Number of patients with depression
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Methods
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Using the online system Qualtrics, an anonymous survey was
created and sent to 1,205 eligible patients from the National
Registry for DM and FSHD Patients and Family Members at the
University of Rochester. To participate, patients had to be at
least 18 years old, be a member of the Registry, and have been
diagnosed with DM or FSHD. The survey included 65
questions on demographic information, depression, medication
use and effectiveness, and non-pharmacological techniques.
The survey was available from May 2017 to August 2017. All
the information was kept anonymous. The study was approved
by the St. John Fisher College Institutional Review Board and
the Registry Scientific Advisory Committee.
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Table 1. Demographic Information
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Table 3. Non-pharmacological techniques used
Technique Used

Patients using technique (n=173)

Exercise

57 (33%)

Gender

DM1 (n=135)

DM2 (n=74)

FSHD (n=221)

Male

62 (46%)

27 (36%)

110 (48%)

Meditation

77 (45%)

Female

73 (54%)

47 (64%)

111 (50%)

Counseling

27 (16%)

Conclusion
Many patients with DM and FSHD have been diagnosed with
depression. To manage this, patients are using both pharmacologic
and non-pharmacologic strategies. It was found that their depression
is being managed in a similar way to the general population2. Patients
are also widely using non-pharmacologic techniques which they
believe are helping them in managing depression. To conclude,
people with DM and FSHD utilize non-pharmacological techniques in
the management of their depression in a similar way to the general
population3.
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